Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Kortrijk – page 139

2 274 clinical trials in Kortrijk, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kortrijk at a glance
2 274
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 274 trials in Kortrijk

Open in trial search

Nephrotic syndrome

Not recruiting

Study on Obinutuzumab vs. Rituximab for Children with Steroid-Dependent and Frequent Relapsing Nephrotic Syndrome

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Obinutuzumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.

Gastric cancer

Not recruiting

Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Centre Leon Berard

Hidradenitis

Not recruiting

Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Fabry's disease

Not recruiting

Study on Long-Term Safety of Oral Lucerastat for Adults with Fabry Disease

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Lucerastat
  • Sponsor:Idorsia Pharmaceuticals Ltd.

Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Centre Francois Baclesse

Acute myeloid leukaemia+1

Not recruiting

Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Institut Paoli-Calmettes

Critical illness

Not recruiting

Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tetracosactide
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Macitentan
  • Sponsor:Assistance Publique Hopitaux De Paris

Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Glaxosmithkline Research & Development Limited

Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:Xcovery Holding Co. LLC

Plasma cell leukaemia

Not recruiting

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Assistance Publique Hopitaux De Paris

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Kortrijk

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple cancer types, including advanced research in prostate cancer, melanoma, and breast cancer treatments. Studies evaluating novel therapeutic combinations and targeted approaches for improved patient outcomes.

  • Metastatic Prostate Cancer
  • Breast Cancer Therapies
  • Melanoma Treatments
  • Multiple Myeloma

Research emphasizes personalized treatment approaches and combination therapies to enhance effectiveness.

02 Cardiovascular Studies

Comprehensive research into cardiovascular diseases and related conditions, including trials for stroke prevention, atrial fibrillation, and coronary artery disease management.

  • Stroke Prevention
  • Atrial Fibrillation
  • Deep Vein Thrombosis
  • Coronary Artery Disease

Focus on innovative therapeutic approaches and preventive strategies for cardiovascular conditions.

03 Neurological & Chronic Conditions

Studies investigating treatments for neurological disorders and chronic conditions, including Alzheimer's disease, chronic kidney disease, and viral infections.

  • Alzheimer's Disease
  • Chronic Kidney Disease
  • Viral Lung Infections
  • Hepatitis B

Research aimed at developing effective treatments and improving patient quality of life.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.